PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma. Editorial Article uri icon

Overview

publication date

  • January 14, 2022

Research

keywords

  • Melanoma
  • Skin Neoplasms

Identity

PubMed Central ID

  • PMC9061142

Scopus Document Identifier

  • 85129779696

Digital Object Identifier (DOI)

  • 10.1200/JCO.21.02801

PubMed ID

  • 35030031

Additional Document Info

volume

  • 40

issue

  • 13